Introduction: The Anesthesia Subsidy Conundrum
When hospitals negotiate anesthesia coverage agreements, they're not actually buying "FTEs." They're buying a coverage promise—reliable, safe anesthesia across main ORs and procedural sites, including the unpredictable edges: OB, trauma, cath/EP, GI, IR, and the expanding NORA universe. That promise carries real costs that a headcount-times-median spreadsheet simply can't capture.
Meanwhile, direct hospital payments to anesthesia groups—commonly called stipends or subsidies—have grown both more common and larger in many markets, particularly where public-payer exposure runs high. That backdrop explains why valuation shortcuts so often fail when scrutinized. The stakes are real: get the methodology wrong, and you're exposed to regulatory risk. Get it right, and you've documented a defensible arrangement that secures critical access for your patients.
Why the "FTE × Median – Collections" Shortcut Breaks
The classic shortcut treats an FTE like a fungible commodity—plug in a number, multiply by a median, subtract collections, and call it done. But in practice, anesthesia staffing is governed by what we might call "coverage physics": start-time peaks and room turnover patterns, medical direction and concurrency rules, call design (in-house versus beeper; weekday versus weekend), and subspecialty needs that range from cardiothoracic to pediatrics to high-acuity OB. Those operational realities drive role-specific compensation and overhead that broad multi-specialty medians simply blur over.
Benchmark choice matters more than people think. "Total cash compensation" gets reported inconsistently—sometimes call premiums are in, sometimes they're out. Contemporary market signals, like GasWork job postings, aren't a primary dataset for valuation, but they do corroborate the wide dispersion you see by call burden, geography, and role. They're useful context when you need to explain why an OB-heavy CRNA line or a CT-trained MD prices very differently than a weekday ASC line.
One more practical point: it's common for revenue inputs to come from the parties themselves. That's fine when you're valuing support—the valuation can focus squarely on the economics of furnishing coverage, treating collections as a documented input rather than an independent projection. (For context: anesthesia professional payment typically follows Base Units + Time Units × payer-specific conversion factors, but that's a revenue mechanics question, not a valuation question.)
What "Granular and Defensible" Actually Looks Like (Cost-Side Focus)
A credible model starts from your coverage map—rooms and sites, hours and day-parts, call and backup obligations—and converts those promises into required staffing by role under compliant concurrency standards. From there, you build a cost stack that can withstand scrutiny:
Role-specific compensation that prices the actual work: call categories, off-shift coverage, subspecialty requirements (CT, peds), and setting differences (OB versus ASC), all anchored in anesthesia-specific sources and corroborated with contemporaneous market signals where appropriate.
Benefits and employer costs: health and retirement, payroll taxes, PTO and CME, malpractice (including tail considerations when someone leaves).
Practice overhead and infrastructure: billing and CBO fees, credentialing and recruiting, scheduling software, quality and compliance programs, IT and EMR, malpractice premiums, leadership and admin time, licensure and NPDB fees, plus reasonable corporate services.
Working-capital and staffing risk: receivables float, vacancy and locums contingencies, onboarding churn, and the exposure to premium pay when you need coverage on short notice.
This cost view stands independent of your collections model. It can be reproduced, audited, and stress-tested against alternate scenarios. And labor-market context remains directly relevant here: persistent anesthesia workforce constraints make staffing risk and premium pay exposure more than theoretical—they directly influence your cost stack.
Two Valuation Paths You Can Defend
You have two methodological paths, and both can be defended if documented correctly. Each pathway below stands on its own—you can read either column independently, or compare them side by side to choose the right fit for your arrangement.
| Methodology | Make-Whole (Break-Even Cost) | Enterprise Return (Margin-Inclusive) |
|---|---|---|
| Purpose | Estimate the minimum hospital payment required to cover the provider's total economic cost of delivering the specified anesthesia service bundle, with no residual profit. | Estimate a hospital payment that covers total economic cost plus a reasonable return for an independent enterprise furnishing coverage under material operating and financial risk. |
| Operational Fit | Works best where the hospital already shoulders significant enterprise burdens—substantial in-kind support, hospital-owned billing, quasi-employment dynamics—or where vacancy risk is low and the coverage footprint is relatively predictable. | Fits arrangements with a truly independent group that funds its own payroll and AR, manages recruiting and credentialing, maintains leadership and admin infrastructure, and guarantees 24/7 coverage with real vacancy and standby risk. |
| Cost Inputs | Role-specific compensation (with call differentials), benefits and taxes, necessary overhead to meet coverage and quality specs, prudent staffing-risk contingencies, and transparent documentation of every line item. | Everything in the make-whole column, plus explicit recognition of enterprise burdens—cash-flow timing, credit facilities, recruiting pipelines, IT and QA programs—that persist regardless of daily case volume. |
| Treatment of Return | No explicit residual profit. The result is simply the net deficit after economic cost. | Adds a reasonable enterprise return tied to the risk-bearing and working-capital needs of a third-party service provider. Priced without any reference to downstream referral value. |
| Evidence Package | Coverage map, staffing physics and concurrency guardrails, compensation sources with adjustments for call and setting, overhead schedule, contingency rationale, and a clear statement that revenue figures are external inputs to the model. | Everything in the make-whole package, plus documentation of economic risk (payroll-to-collection timing, vacancy and locums exposure, credit lines or working-capital facilities), and a short memo anchoring return reasonableness to comparable service vendors or capital costs. |
| Durability in Tight Labor Markets | Vulnerable when wages rise or vacancies persist. Reliance on locums can quickly overwhelm a break-even structure, especially given ongoing workforce shortages. | Generally more resilient because staffing risk and capital costs are already recognized and priced. Still requires disciplined documentation so the return is plainly linked to risk and operations—not business generation. |
Context: Why This Conversation Keeps Escalating
Across multiple studies and policy briefs, both the prevalence and magnitude of anesthesia stipends have increased—especially in hospitals serving a higher share of publicly insured patients. That trend doesn't dictate what your hospital should pay, but it underscores why valuation must be tailored to your specific coverage requirements, role mix, and risk profile rather than defaulting to a generic FTE average.
Closing Thought
Defensibility comes from granularity, documentation, and reproducibility. Start with the coverage promise. Price the actual roles required to keep that promise. Build overhead and risk into your cost stack with evidence. Then decide—based on who actually bears enterprise risk—whether a reasonable return belongs in the number. In today's workforce environment, with persistent shortages and rising locums costs, that discipline is how hospitals secure dependable anesthesia access and maintain a record that stands up to scrutiny when questions come.
Continue Reading
Ready to explore when margin-based approaches are appropriate? Continue to Part 2: When Is Margin Appropriate? →